Tokyo Tape
Sign in
← Trans Genic

Quarterly report · Q3

2342.TEDINET S100STDC
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥9.7bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥11.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥8.5bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥52m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥153m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥51m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥199m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥385m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥7m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥344m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥38m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥410m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥182m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥43m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥171m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥10.4bnat 2023-12-31Cons.Assets
Total assets¥10.7bnat 2023-03-31Cons.Assets
Total assets¥10.9bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥4.4bnat 2023-12-31Cons.Liabilities
Total liabilities¥4.6bnat 2023-03-31Cons.Liabilities
Net assets / equity¥6.0bnat 2023-12-31Cons.Net assets
Net assets / equity¥6.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥6.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.8bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥3.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥-2.272023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.152023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-24.322022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.812022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.542022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio56.7%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.4%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥5m
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-12-31¥450,000
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥5m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥152m
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥1.6bn
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.6bn
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥5m
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentsegment profit2023-04-01 → 2023-12-31−¥109m
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥8.1bn
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥8.1bn
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥760,000
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥313m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥9.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥9.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥5m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥204m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥4m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31¥2m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥6m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥157m
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5m
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥132m
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥1m
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥179m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥8.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥8.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥6m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥310m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 361
ItemContextValueUnit
Accounts payable otherPrior1YearInstant284024000JPY
Accounts payable otherCurrentQuarterInstant258809000JPY
Short term loans payablePrior1YearInstant170000000JPY
Short term loans payableCurrentQuarterInstant748000000JPY
Current portion of bondsPrior1YearInstant14000000JPY
Current portion of bondsCurrentQuarterInstant14000000JPY
Current portion of long term loans payablePrior1YearInstant478032000JPY
Current portion of long term loans payableCurrentQuarterInstant466964000JPY
Income taxes payablePrior1YearInstant57378000JPY
Income taxes payableCurrentQuarterInstant32157000JPY
Advances receivedPrior1YearInstant969958000JPY
Advances receivedCurrentQuarterInstant601576000JPY
Provision for bonusesPrior1YearInstant23388000JPY
Provision for bonusesCurrentQuarterInstant28604000JPY
Provision for loss on order received clPrior1YearInstant63000JPY
Provision for loss on order received clCurrentQuarterInstant1104000JPY
Other clPrior1YearInstant338403000JPY
Other clCurrentQuarterInstant204759000JPY
Current liabilitiesPrior1YearInstant2743992000JPY
Current liabilitiesCurrentQuarterInstant2884402000JPY
Bonds payablePrior1YearInstant137000000JPY
Bonds payableCurrentQuarterInstant130000000JPY
Long term loans payablePrior1YearInstant1569482000JPY
Long term loans payableCurrentQuarterInstant1291273000JPY
Long term accounts payable otherPrior1YearInstant27562000JPY
Long term accounts payable otherCurrentQuarterInstant15461000JPY
Net defined benefit liabilityPrior1YearInstant40892000JPY
Net defined benefit liabilityCurrentQuarterInstant37783000JPY
Other nclPrior1YearInstant31482000JPY
Other nclCurrentQuarterInstant27111000JPY
Noncurrent liabilitiesPrior1YearInstant1806419000JPY
Noncurrent liabilitiesCurrentQuarterInstant1501628000JPY
LiabilitiesPrior1YearInstant4550412000JPY
LiabilitiesCurrentQuarterInstant4386031000JPY
Capital stockPrior1YearInstant50000000JPY
Capital stockCurrentQuarterInstant50000000JPY
Capital surplusPrior1YearInstant3869990000JPY
Capital surplusCurrentQuarterInstant3861314000JPY
Retained earningsPrior1YearInstant2147300000JPY
Retained earningsCurrentQuarterInstant2024694000JPY
Treasury stockPrior1YearInstant-76915000JPY
Treasury stockCurrentQuarterInstant-110794000JPY
Shareholders equityPrior1YearInstant5990375000JPY
Shareholders equityCurrentQuarterInstant5825214000JPY
Valuation difference on available for sale securitiesPrior1YearInstant9064000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant20874000JPY
Foreign currency translation adjustmentPrior1YearInstant18401000JPY
Foreign currency translation adjustmentCurrentQuarterInstant22234000JPY
Valuation and translation adjustmentsPrior1YearInstant27465000JPY
Valuation and translation adjustmentsCurrentQuarterInstant43108000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass